基于pyrazole的combretastatin A-4类似物作为潜在的细胞毒剂的设计,合成和生物评估
Mai H Omar1, Soha H Emam2, Demiana S Mikhail2
1Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt..
Bioorganic chemistry
|June 20, 2025
概括
基于皮拉的新化合物通过抑制氨酸聚合并诱导亡,显示出强大的抗癌活性. 化合物4a在多个癌症细胞系中表现出显著的生长抑制,使其成为有前途的治疗候选者.
科学领域:
- 药用化学 医学化学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 康布列塔斯A-4 (CA-4) 是一种强大的抗癌剂,但其临床用途有限.
- 开发具有增强疗效和改进性质的新型类似物对于癌症治疗至关重要.
研究的目的:
- 设计和合成基于皮拉的新型康培拉酸A-4类似物.
- 评估这些新化合物对各种癌症细胞系的细胞毒性活性和作用机制.
主要方法:
- 使用 chalcone 类似物合成 pyrazoline 衍生物 (4a-g).
- 在体外细胞毒性评估与NCI-60癌细胞小组和特定细胞系 (A549,OVCAR-4) 相比.
- 评估管氨酸聚合抑制,反应性氧物种 (ROS) 生产,线粒体膜潜力,酶-3表达和分子对接研究.
主要成果:
- 化合物4a对多种癌细胞系,特别是A549和OVCAR-4 (IC50值分别为5.93和3.46μM) 具有显著的细胞毒性活性.
- 化合物4a对癌细胞比正常细胞具有选择性 (A549的选择性指数为7.2).
- 作用机制包括素聚合抑制,ROS生成 (243%的增加),线粒体功能障碍和亡诱导 (caspase-3的3.7倍增加).
结论:
- 皮拉衍生物4a是一种强大的抗癌剂,具有有前途的治疗特征.
- 该化合物作为氨酸聚合抑制剂,并通过ROS介导的途径诱导亡.
- 化合物4a代表了一种潜在的新药可用于治疗癌症的分子.
相关概念视频
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


